Published in Cancer Weekly, May 6th, 1996
The peptide mediates hypercalcemia, which contributes to the development of certain hematologic cancers. That's according to Dr. Richard Kremer and associates at McGill University in Montreal, Quebec, Canada. They compared parathyroid hormone-related peptide concentrations in 30 normal subjects and in 76 patients with either non-Hodgkin's lymphoma, Hodgkin's disease, multiple myeloma, or Waldenstrom's macroglobulinemia. Fourteen of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.